BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 1969784)

  • 1. Effects of antacids on the clinical pharmacokinetics of drugs. An update.
    Gugler R; Allgayer H
    Clin Pharmacokinet; 1990 Mar; 18(3):210-9. PubMed ID: 1969784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.
    Stass H; Böttcher MF; Ochmann K
    Clin Pharmacokinet; 2001; 40 Suppl 1():39-48. PubMed ID: 11352441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short report: a comparative study of the interaction between antacid and H2-receptor antagonists.
    Sullivan TJ; Reese JH; Jauregui L; Miller K; Levine L; Bachmann KA
    Aliment Pharmacol Ther; 1994 Feb; 8(1):123-6. PubMed ID: 7910488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug interactions of H2-receptor antagonists.
    Bachmann KA; Sullivan TJ; Jauregui L; Reese J; Miller K; Levine L
    Scand J Gastroenterol Suppl; 1994; 206():14-9. PubMed ID: 7863246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug interactions with antacids. Mechanisms and clinical significance.
    Sadowski DC
    Drug Saf; 1994 Dec; 11(6):395-407. PubMed ID: 7727050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral bioavailability of nizatidine and ranitidine concurrently administered with antacid.
    Desager JP; Harvengt C
    J Int Med Res; 1989; 17(1):62-7. PubMed ID: 2565267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of metal-cation antacids on the pharmacokinetics of 1200 mg raltegravir.
    Krishna R; East L; Larson P; Valiathan C; Butterfield K; Teng Y; Hernandez-Illas M
    J Pharm Pharmacol; 2016 Nov; 68(11):1359-1365. PubMed ID: 27671833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of drug absorption by antacids. An unrecognised drug interaction.
    Neuvonen PJ; Kivistö KT
    Clin Pharmacokinet; 1994 Aug; 27(2):120-8. PubMed ID: 7955775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired bioavailability of famotidine given concurrently with a potent antacid.
    Barzaghi N; Gatti G; Crema F; Perucca E
    J Clin Pharmacol; 1989 Jul; 29(7):670-2. PubMed ID: 2569486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin.
    Nix DE; Watson WA; Lener ME; Frost RW; Krol G; Goldstein H; Lettieri J; Schentag JJ
    Clin Pharmacol Ther; 1989 Dec; 46(6):700-5. PubMed ID: 2598571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of food and various antacids on the absorption of tenoxicam.
    Day RO; Lam S; Paull P; Wade D
    Br J Clin Pharmacol; 1987 Sep; 24(3):323-8. PubMed ID: 3499163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of antacids and food on absorption of famotidine.
    Lin JH; Chremos AN; Kanovsky SM; Schwartz S; Yeh KC; Kann J
    Br J Clin Pharmacol; 1987 Oct; 24(4):551-3. PubMed ID: 2891370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of antacid and H2 receptor antagonists on the intestinal absorption of folic acid.
    Russell RM; Golner BB; Krasinski SD; Sadowski JA; Suter PM; Braun CL
    J Lab Clin Med; 1988 Oct; 112(4):458-63. PubMed ID: 2902178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of an aluminum- and magnesium-containing antacid on the bioavailability of garenoxacin in healthy volunteers.
    Krishna G; Kisicki JC; Olsen S; Grasela DM; Wang Z
    Pharmacotherapy; 2007 Jul; 27(7):963-9. PubMed ID: 17594201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically significant drug interactions with antacids: an update.
    Ogawa R; Echizen H
    Drugs; 2011 Oct; 71(14):1839-64. PubMed ID: 21942976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the antacid Maalox and the H2-antagonist cimetidine on the pharmacokinetics of cerivastatin.
    Mück W; Ritter W; Dietrich H; Frey R; Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):261-4. PubMed ID: 9208343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG; Berstad A
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.
    Verbeeck RK
    Clin Pharmacokinet; 1990 Jul; 19(1):44-66. PubMed ID: 2199127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale for ibuprofen co-administration with antacids: potential interaction mechanisms affecting drug absorption.
    Parojcić J; Corrigan OI
    Eur J Pharm Biopharm; 2008 Jun; 69(2):640-7. PubMed ID: 18280125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of meloxicam with cimetidine, Maalox, or aspirin.
    Busch U; Heinzel G; Narjes H; Nehmiz G
    J Clin Pharmacol; 1996 Jan; 36(1):79-84. PubMed ID: 8932547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.